Overview

Howard Suh is a partner in Holland & Knight’s New York office. Mr. Suh focuses his intellectual property practice on patent litigation and counseling, with an emphasis on pharmaceuticals and biotechnology. He has tried some of the largest patent cases in these areas, and is active in appellate litigation at the Federal Circuit and Supreme Court.

In the biotechnology sector, Mr. Suh has litigated and provided advice on patents related to some of the most important biopharmaceuticals, including recombinantly-produced insulin, human growth hormone (HGH), tissue plasminogen activator (t-PA), erythropoietin (EPO), granulocyte colony-stimulating factor (G-CSF) and chimeric antibodies.

Mr. Suh also has substantial experience in agricultural biotechnology, having represented multinational crop-sciences companies in patent litigation involving genetically modified corn and soybean seeds.

On the pharmaceutical side, Mr. Suh has handled a wide variety of patent litigations on small-molecule drugs, in fields ranging from oncology and immunology to cough-and-cold products.

In addition, Mr. Suh has litigated patent cases in a variety of other fields, ranging from medical devices to material science. He also assists clients in corporate transactions and acquisitions, performing due diligence of patent portfolios, evaluating threats from competitive patents and preparing agreements.

Experience

  • Co-lead counsel representing major branded company involving kidney cancer therapy and formulation, resulting in favorable settlement
  • Co-lead counsel representing major branded company involving transplant rejection drug, resulting in favorable judgment after trial
  • Lead counsel representing major branded company involving over the counter cold and sinus formulation, resulting in favorable settlement without generic entry

  • Successful defense of ITC patent infringement action representing global pharmaceutical company involving erythropoiesis stimulating agents, leading to jury trial, and worldwide settlement 
  • Successful jury trial representing plaintiff on patents covering NF-kB pathway 
  • Successful settlement for patentee covering pioneering inventions relating to bacterial expression systems 
  • Successful defense of patent infringement on jury verdict related to recombinant production of antibodies 
  • Successful defense of patent infringement on summary judgment related to Fabry disease drug and homologous recombination technology 
  • Successful settlement representing patentee on inventions covering recombinant tissue plasminogen activator 
  • Successful appeal reversing lower court relating to recombinant human growth hormone 
  • Successful settlement after jury verdict involving recombinant human growth hormone 
  • Successful settlement of patent infringement claims involving recombinant insulin

  • Global settlement representing major chemical and life sciences company following jury trial involving transgenic herbicide tolerant soybeans
  • Successful settlement on the eve of trial representing major chemical and life sciences company involving genetically modified insect resistant corn
  • Successful defense of patent infringement claims representing major chemical and life sciences on summary judgment related to transgenic insect resistant crops
  • Successful settlement representing major chemical and life sciences following jury trial involving transgenic insect resistant corn

  • Co-lead counsel defending major industry player in the field of laser hair removal resulting in successful settlement
  • Co-lead counsel representing patentee in the field of laser acne and wrinkle removal resulting in successful settlement
  • Global settlement representing major chemical and life sciences company in the field of ultrasound and CT scan technology

Credentials

Education
  • New York University School of Law, J.D.
  • Columbia University, B.A.
Bar Admissions/Licenses
  • New York
Court Admissions
  • U.S. Court of Appeals for the Federal Circuit

Publications

News